A recent branch of cardiovascular medicine called molecular cardiology seeks to use molecular biology methods for the mechanistic analysis, detection, diagnosis, and therapy of cardiovascular illness. Its main objective is to identify novel pathways that affect cardiac hypertrophy, ageing, and metabolic disorders, paying close attention to how each discovery might be translated into fresh bedside methods and tactics.
Cellular cardiology: Heart failure is among the leading causes of death in the modern world. The study of the heart or circulatory system at the cellular level is known as cellular cardiology. In this molecular cardiology, the researchers found that the cells in various heart regions differed significantly from one another and that each part of the organ included a distinct group of cells, revealing various developmental origins and possibly varying responses to therapies. The molecular and cellular biology methods that are most frequently employed include:
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain
Title : Back to basics: The pharmacokinetics of direct oral anticoagulants in short-gut syndrome
Abhishek Chandra, Abbott Northwestern Hospital, United States
Title : Clinical pharmacology of sotatercept - The novel quality advancement in biological therapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia